NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/15/2025
Back to search
Official data from USPTO
ELION THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ELION THERAPEUTICS
ST13
US500000098301402Class
42
Filing
98301402
Registration
7757756
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
04/16/2025
Trademark type
Word
Nice classes
42
Filing date
12/06/2023
Registration date
04/15/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/15/2025
Last transaction
04/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/10/2024
First use in commerce
01/10/2024
Drawing code
4
Owner type
03
Owner location
NEW YORK, NY
Examiner
LUEKEN, ABIGAIL
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ELION THERAPEUTICS, INC.
Sfunga Therapeutics, Inc.
Representatives
J. Dickson Phillips III Robinson Bradshaw & Hinson, P.A.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/15/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/25/2025
PUBO
PUBLISHED FOR OPPOSITION
02/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/06/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
09/03/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
09/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2024
GNRT
NON-FINAL ACTION E-MAILED
07/05/2024
CNRT
NON-FINAL ACTION WRITTEN
07/05/2024
IUAA
USE AMENDMENT ACCEPTED
07/05/2024
DOCK
ASSIGNED TO EXAMINER
07/05/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/23/2024
IUAF
USE AMENDMENT FILED
05/23/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/23/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2024
NWAP
NEW APPLICATION ENTERED
12/06/2023
Continuous trademark protection
Get notified about every new filing that threatens ELION THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.